Evidence map›Paper›PMID 21952047›Full record

ArticleThe EMBO journal2011

PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin.

Jianzhong Zhu, Carolyn B Coyne, Saumendra N Sarkar

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Tale of Two: When Neural Stem Cells Encounter Hypoxia.Cellular and molecular neurobiology · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. HDAC6: A unique HDAC family member as a cancer target.Cellular oncology (Dordrecht, Netherlands) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. MicroRNA Interference in Hepatic Host-Pathogen Interactions.International journal of molecular sciences · 2021
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jianzhong ZhuCancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Carolyn B Coyne
Saumendra N Sarkar
UPMC Hillman Cancer Center · USUniversity of Pittsburgh · US

Funding

Novel Modifiers of Toll-like and RIG-like Receptor SignalingU24AI082673 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SARKAR, SAUMENDRA N · 2009 to 2013
$1.5M
NIAID NIH HHS AI082673NIAID NIH HHS U24 AI082673
6 · The paper itself

Abstract

Recognition of viral RNA by cytoplasmic retinoic acid inducible gene I (RIG-I)-like receptors initiates signals leading to the induction of type I interferon (IFN) transcription via transcription factors such as interferon regulatory factor 3 (IRF3) and nuclear factor κB (NF-κB). Here, we describe a new signalling pathway that involves protein kinase C alpha (PKCα), histone deacetylase 6 (HDAC6) and beta-catenin (β-catenin), which is essential for IFN gene induction following virus infection. Knockdown of PKCα in various human cells, including primary cells, inhibited Sendai virus (SeV)-mediated IFN induction and enhanced virus replication. In the absence of this pathway IRF3 becomes activated, but does not bind to its promoter and is thus unable to support transcription. Mechanistically, SeV infection induced the activation of PKCα, which promoted its interaction with HDAC6 and enhanced its deacetylation activity in a phosphorylation-dependent manner. Further downstream, HDAC6 caused deacetylation of β-catenin and enhanced its nuclear translocation and promoter binding. In the nucleus, β-catenin acted as a co-activator for IRF3-mediated transcription. Our findings suggest an important role of a novel signalling pathway mediated by PKCα-HDAC6-β-catenin in controlling IRF3-mediated transcription.

Indexed as

Active Transport, Cell Nucleusbeta CateninCell NucleusCells, CulturedHEK293 CellsHistone DeacetylasesHumansImmunity, InnateInterferon Regulatory Factor-3Interferon Type INF-kappa BPhosphorylationProtein Kinase C-alphaRNA, Small InterferingSendai virusSignal Transductionbeta CateninHistone DeacetylasesInterferon Regulatory Factor-3Interferon Type INF-kappa BProtein Kinase C-alphaRNA, Small Interfering

Identifiers

PMID21952047
PMCPMC3243614
OpenAlexW1590355453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.